Page last updated: 2024-09-04

nevadensin and Colonic Neoplasms

nevadensin has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alfke, J; Bücksteeg, D; Esselen, M; Müller, L; Schütte, LRF; Uebel, T	1

Other Studies

1 other study(ies) available for nevadensin and Colonic Neoplasms

Article	Year
Topoisomerase poisoning by the flavonoid nevadensin triggers DNA damage and apoptosis in human colon carcinoma HT29 cells. Archives of toxicology, 2021, Volume: 95, Issue:12 Topics: Apoptosis; Cell Cycle; Colonic Neoplasms; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Flavones; HT29 Cells; Humans; Inhibitory Concentration 50; Poly-ADP-Ribose Binding Proteins; Time Factors	2021

Article

Year

Topoisomerase poisoning by the flavonoid nevadensin triggers DNA damage and apoptosis in human colon carcinoma HT29 cells.

Archives of toxicology, 2021, Volume: 95, Issue:12

Topics: Apoptosis; Cell Cycle; Colonic Neoplasms; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Flavones; HT29 Cells; Humans; Inhibitory Concentration 50; Poly-ADP-Ribose Binding Proteins; Time Factors

2021